ANNOUNCING: Fina Biosolutions licenses CRM197 vaccine component to PATH to develop important vaccines for use in low-income countries. finabio.net/fina-biosoluti…
Fina Biosolutions will be presenting on our conjugate vaccine carrier protein program at the International Society of Vaccines meeting in Atlanta, Oct 28-30 and Vaccine R&D meeting in Baltimore, Nov 13-15.
FinaBio will be at the World Vaccine Congress, Washington DC April 3-5. We will have 2 poster presentations on our recombinant CRM197 conjugate vaccine carrier protein. One poster will be a biophysical... facebook.com/finabiosolutio…